Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: CAUTIOUS
3
Nov 30, 2007 09:49AM
2
Nov 30, 2007 10:03AM
1
Nov 30, 2007 10:07AM

Nov 30, 2007 10:11AM
2
Nov 30, 2007 10:13AM
2
Nov 30, 2007 10:15AM

Nov 30, 2007 10:16AM

Nov 30, 2007 10:22AM
1
Nov 30, 2007 10:32AM

Nov 30, 2007 10:40AM

Nov 30, 2007 10:56AM
12
Nov 30, 2007 11:54AM
2
Nov 30, 2007 01:16PM
3
Nov 30, 2007 01:39PM

Nov 30, 2007 02:39PM

Nov 30, 2007 04:28PM
1
Nov 30, 2007 04:42PM
6
Nov 30, 2007 04:51PM
1
Dec 01, 2007 12:33PM

Re: CAUTIOUS

in response to by
posted on Dec 02, 2007 07:39AM

Good points plyd.

 

But it will pleasantly surprise me if PTSC can match, much less exceed, the settlement revenue in the succeeding few quarters after the settlement.

 

This is why I’ve said that it is very important for Alliacense to totally understand their licensing bottleneck issues and resolve all their capacity issues before settlement. The revenue in the quarters after a settlement could make a huge difference in how PTSC is perceived – a fast growing company, or a one shot flash in the pan followed by mediocre earnings. This perception and PPS will then impact their ability to build or aquire additional revenue streams.

 

By the way, I think Alliancese has shown some signs of making improvements to their licensing systems and capacity – the hiring they’ve done may be an indication.

 

1
Dec 02, 2007 08:02AM
10
Dec 03, 2007 05:27PM
2
Dec 03, 2007 06:23PM
Share
New Message
Please login to post a reply